Trials / Completed
CompletedNCT05475301
Incidence, Risk Factor, Treatment and Overall Survival of Locally Recurrent Rectal Cancer
Incidence, Risk Factor, Treatment and Overall Survival of Locally Recurrent Rectal Cancer: a Retrospective, Population-based Cohort Study
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,431 (actual)
- Sponsor
- Radboud University Medical Center · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Data on disease recurrence was collected for all primary rectal cancer patients diagnosed in the Netherlands over the first six months of 2015. Three-year cumulative incidence, risk factors, treatment and three-year OS of locally recurrent rectal cancer were determined.
Conditions
Timeline
- Start date
- 2015-01-01
- Primary completion
- 2015-06-30
- Completion
- 2015-06-30
- First posted
- 2022-07-26
- Last updated
- 2023-11-18
Source: ClinicalTrials.gov record NCT05475301. Inclusion in this directory is not an endorsement.